Eprodisate Disodium

Eprodisate disodium has been primarily investigated for its application in treating amyloidosis, particularly AA amyloidosis. Its ability to inhibit fibril formation makes it a candidate for clinical use in managing renal complications associated with this condition. Moreover, research continues into its potential benefits in other diseases characterized by protein misfolding and aggregation.

The biological activity of eprodisate disodium is primarily linked to its ability to inhibit the formation of amyloid fibrils. By binding to serum amyloid A, it disrupts the normal assembly process of amyloid proteins, which are implicated in various diseases such as renal disease associated with amyloidosis. Studies have shown that this compound can lead to reduced amyloid deposits in affected tissues, providing a therapeutic avenue for managing conditions like AA amyloidosis.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.